As of May 27
| +0.17 / +2.38%|
The 6 analysts offering 12-month price forecasts for GenMark Diagnostics Inc have a median target of 8.50, with a high estimate of 11.00 and a low estimate of 6.50. The median estimate represents a +16.12% increase from the last price of 7.32.
The current consensus among 7 polled investment analysts is to Buy stock in GenMark Diagnostics Inc. This rating has held steady since May, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.